시장조사 보고서 : 세계의 파지 요법 시장예측 2021년-2026년

■ 영문 제목 : Global Phage Therapy Market Growth (Status and Outlook) 2021-2026
	■ 상품코드 : LPI-2201K02268 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 120 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦4,941,000	견적의뢰/주문/질문
Multi User (5명 열람용)	USD5,490 ⇒환산￦7,411,500	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦9,882,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 파지 요법의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (DsDNA 박테리오파지, SsDNA 박테리오파지, SsRNA 박테리오파지, 기타)와 용도별 시장규모 (동물 건강, 수산 양식, 농업, 식품 산업, 건강, 기타) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 파지 요법 시장 점유율
- 지역별 파지 요법 시장규모
- 주요지역의 종류별 시장규모 (DsDNA 박테리오파지, SsDNA 박테리오파지, SsRNA 박테리오파지, 기타)
- 주요지역의 용도별 시장규모 (동물 건강, 수산 양식, 농업, 식품 산업, 건강, 기타)
- 미주의 파지 요법 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 파지 요법 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 파지 요법 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 파지 요법 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 파지 요법 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
NPO Microgen, Proteon Pharmaceuticals, Phagelux, Intralytix, Micreos, Eliava BioPreparations, Locus Biosciences,Inc, Pharmex Group,LLC, Pherecydes Pharma, APS Biocontrol Ltd. (APS), Qingdao Phagepharm Bio-tech, Fixed-Phage Limited, Zeptometrix, Phage International, Inc., MicroMir, iNtODEWORLD, Inc., NEXTBIOTICS, Armata Pharmaceut
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Phage Therapy will have significant change from previous year. By the most conservative estimates of global Phage Therapy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 28 million in 2020. Over the next five years the Phage Therapy market will register a 18.3% CAGR in terms of revenue, the global market size will reach US$ 55 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Phage Therapy market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
NPO Microgen
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences,Inc
Pharmex Group,LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Phage Therapy Market Size 2016-2026
2.1.2 Phage Therapy Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Phage Therapy Segment by Type
2.2.1 DsDNA Bacteriophage
2.2.2 DsDNA Bacteriophage
2.2.3 SsRNA Bacteriophage
2.2.4 Others
2.3 Phage Therapy Market Size by Type
2.3.1 Global Phage Therapy Market Size CAGR by Type
2.3.2 Global Phage Therapy Market Size Market Share by Type (2016-2021)
2.4 Phage Therapy Segment by Application
2.4.1 Animal Health
2.4.2 Aquaculture
2.4.3 Agriculture
2.4.4 Food Industry
2.4.5 Human Health
2.4.6 Others
2.5 Phage Therapy Market Size by Application
2.5.1 Global Phage Therapy Market Size CAGR by Application
2.5.2 Global Phage Therapy Market Size Market Share by Application (2016-2021)

3 Phage Therapy Market Size by Players
3.1 Phage Therapy Market Size Market Share by Players
3.1.1 Global Phage Therapy Revenue by Players (2019-2021E)
3.1.2 Global Phage Therapy Revenue Market Share by Players (2019-2021E)
3.2 Global Phage Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Phage Therapy by Regions
4.1 Phage Therapy Market Size by Regions (2016-2021)
4.2 Americas Phage Therapy Market Size Growth (2016-2021)
4.3 APAC Phage Therapy Market Size Growth (2016-2021)
4.4 Europe Phage Therapy Market Size Growth (2016-2021)
4.5 Middle East & Africa Phage Therapy Market Size Growth (2016-2021)

5 Americas
5.1 Americas Phage Therapy Market Size by Country (2016-2021)
5.2 Americas Phage Therapy Market Size by Type (2016-2021)
5.3 Americas Phage Therapy Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Phage Therapy Market Size by Region (2016-2021)
6.2 APAC Phage Therapy Market Size by Type (2016-2021)
6.3 APAC Phage Therapy Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Phage Therapy by Country (2016-2021)
7.2 Europe Phage Therapy Market Size by Type (2016-2021)
7.3 Europe Phage Therapy Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Phage Therapy by Region (2016-2021)
8.2 Middle East & Africa Phage Therapy Market Size by Type (2016-2021)
8.3 Middle East & Africa Phage Therapy Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Phage Therapy Market Forecast
10.1 Global Phage Therapy Forecast by Regions (2021-2026)
10.1.1 Global Phage Therapy Forecast by Regions (2021-2026)
10.1.2 Americas Phage Therapy Forecast
10.1.3 APAC Phage Therapy Forecast
10.1.4 Europe Phage Therapy Forecast
10.1.5 Middle East & Africa Phage Therapy Forecast
10.2 Americas Phage Therapy Forecast by Countries (2021-2026)
10.2.1 United States Phage Therapy Market Forecast
10.2.2 Canada Phage Therapy Market Forecast
10.2.3 Mexico Phage Therapy Market Forecast
10.2.4 Brazil Phage Therapy Market Forecast
10.3 APAC Phage Therapy Forecast by Region (2021-2026)
10.3.1 China Phage Therapy Market Forecast
10.3.2 Japan Phage Therapy Market Forecast
10.3.3 Korea Phage Therapy Market Forecast
10.3.4 Southeast Asia Phage Therapy Market Forecast
10.3.5 India Phage Therapy Market Forecast
10.3.6 Australia Phage Therapy Market Forecast
10.4 Europe Phage Therapy Forecast by Country (2021-2026)
10.4.1 Germany Phage Therapy Market Forecast
10.4.2 France Phage Therapy Market Forecast
10.4.3 UK Phage Therapy Market Forecast
10.4.4 Italy Phage Therapy Market Forecast
10.4.5 Russia Phage Therapy Market Forecast
10.5 Middle East & Africa Phage Therapy Forecast by Region (2021-2026)
10.5.1 Egypt Phage Therapy Market Forecast
10.5.2 South Africa Phage Therapy Market Forecast
10.5.3 Israel Phage Therapy Market Forecast
10.5.4 Turkey Phage Therapy Market Forecast
10.5.5 GCC Countries Phage Therapy Market Forecast
10.6 Global Phage Therapy Forecast by Type (2021-2026)
10.7 Global Phage Therapy Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 NPO Microgen
11.1.1 NPO Microgen Company Information
11.1.2 NPO Microgen Phage Therapy Product Offered
11.1.3 NPO Microgen Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 NPO Microgen Main Business Overview
11.1.5 NPO Microgen Latest Developments
11.2 Proteon Pharmaceuticals
11.2.1 Proteon Pharmaceuticals Company Information
11.2.2 Proteon Pharmaceuticals Phage Therapy Product Offered
11.2.3 Proteon Pharmaceuticals Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Proteon Pharmaceuticals Main Business Overview
11.2.5 Proteon Pharmaceuticals Latest Developments
11.3 Phagelux
11.3.1 Phagelux Company Information
11.3.2 Phagelux Phage Therapy Product Offered
11.3.3 Phagelux Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Phagelux Main Business Overview
11.3.5 Phagelux Latest Developments
11.4 Intralytix
11.4.1 Intralytix Company Information
11.4.2 Intralytix Phage Therapy Product Offered
11.4.3 Intralytix Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Intralytix Main Business Overview
11.4.5 Intralytix Latest Developments
11.5 Micreos
11.5.1 Micreos Company Information
11.5.2 Micreos Phage Therapy Product Offered
11.5.3 Micreos Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Micreos Main Business Overview
11.5.5 Micreos Latest Developments
11.6 Eliava BioPreparations
11.6.1 Eliava BioPreparations Company Information
11.6.2 Eliava BioPreparations Phage Therapy Product Offered
11.6.3 Eliava BioPreparations Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Eliava BioPreparations Main Business Overview
11.6.5 Eliava BioPreparations Latest Developments
11.7 Locus Biosciences,Inc
11.7.1 Locus Biosciences,Inc Company Information
11.7.2 Locus Biosciences,Inc Phage Therapy Product Offered
11.7.3 Locus Biosciences,Inc Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Locus Biosciences,Inc Main Business Overview
11.7.5 Locus Biosciences,Inc Latest Developments
11.8 Pharmex Group,LLC
11.8.1 Pharmex Group,LLC Company Information
11.8.2 Pharmex Group,LLC Phage Therapy Product Offered
11.8.3 Pharmex Group,LLC Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Pharmex Group,LLC Main Business Overview
11.8.5 Pharmex Group,LLC Latest Developments
11.9 Pherecydes Pharma
11.9.1 Pherecydes Pharma Company Information
11.9.2 Pherecydes Pharma Phage Therapy Product Offered
11.9.3 Pherecydes Pharma Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Pherecydes Pharma Main Business Overview
11.9.5 Pherecydes Pharma Latest Developments
11.10 APS Biocontrol Ltd. (APS)
11.10.1 APS Biocontrol Ltd. (APS) Company Information
11.10.2 APS Biocontrol Ltd. (APS) Phage Therapy Product Offered
11.10.3 APS Biocontrol Ltd. (APS) Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 APS Biocontrol Ltd. (APS) Main Business Overview
11.10.5 APS Biocontrol Ltd. (APS) Latest Developments
11. Qingdao Phagepharm Bio-tech
11.11.1 Qingdao Phagepharm Bio-tech Company Information
11.11.2 Qingdao Phagepharm Bio-tech Phage Therapy Product Offered
11.11.3 Qingdao Phagepharm Bio-tech Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 Qingdao Phagepharm Bio-tech Main Business Overview
11.11.5 Qingdao Phagepharm Bio-tech Latest Developments
11.12 Fixed-Phage Limited
11.12.1 Fixed-Phage Limited Company Information
11.12.2 Fixed-Phage Limited Phage Therapy Product Offered
11.12.3 Fixed-Phage Limited Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 Fixed-Phage Limited Main Business Overview
11.12.5 Fixed-Phage Limited Latest Developments
11.13 Zeptometrix
11.13.1 Zeptometrix Company Information
11.13.2 Zeptometrix Phage Therapy Product Offered
11.13.3 Zeptometrix Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 Zeptometrix Main Business Overview
11.13.5 Zeptometrix Latest Developments
11.14 Phage International, Inc.
11.14.1 Phage International, Inc. Company Information
11.14.2 Phage International, Inc. Phage Therapy Product Offered
11.14.3 Phage International, Inc. Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.14.4 Phage International, Inc. Main Business Overview
11.14.5 Phage International, Inc. Latest Developments
11.15 MicroMir
11.15.1 MicroMir Company Information
11.15.2 MicroMir Phage Therapy Product Offered
11.15.3 MicroMir Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.15.4 MicroMir Main Business Overview
11.15.5 MicroMir Latest Developments
11.16 iNtODEWORLD, Inc.
11.16.1 iNtODEWORLD, Inc. Company Information
11.16.2 iNtODEWORLD, Inc. Phage Therapy Product Offered
11.16.3 iNtODEWORLD, Inc. Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.16.4 iNtODEWORLD, Inc. Main Business Overview
11.16.5 iNtODEWORLD, Inc. Latest Developments
11.17 NEXTBIOTICS
11.17.1 NEXTBIOTICS Company Information
11.17.2 NEXTBIOTICS Phage Therapy Product Offered
11.17.3 NEXTBIOTICS Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.17.4 NEXTBIOTICS Main Business Overview
11.17.5 NEXTBIOTICS Latest Developments
11.18 Armata Pharmaceuticals, Inc.
11.18.1 Armata Pharmaceuticals, Inc. Company Information
11.18.2 Armata Pharmaceuticals, Inc. Phage Therapy Product Offered
11.18.3 Armata Pharmaceuticals, Inc. Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.18.4 Armata Pharmaceuticals, Inc. Main Business Overview
11.18.5 Armata Pharmaceuticals, Inc. Latest Developments
11.19 Innophage
11.19.1 Innophage Company Information
11.19.2 Innophage Phage Therapy Product Offered
11.19.3 Innophage Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.19.4 Innophage Main Business Overview
11.19.5 Innophage Latest Developments
11.20 Adaptive Phage Therapeutics
11.20.1 Adaptive Phage Therapeutics Company Information
11.20.2 Adaptive Phage Therapeutics Phage Therapy Product Offered
11.20.3 Adaptive Phage Therapeutics Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.20.4 Adaptive Phage Therapeutics Main Business Overview
11.20.5 Adaptive Phage Therapeutics Latest Developments
11.21 TechnoPhage
11.21.1 TechnoPhage Company Information
11.21.2 TechnoPhage Phage Therapy Product Offered
11.21.3 TechnoPhage Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.21.4 TechnoPhage Main Business Overview
11.21.5 TechnoPhage Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Phage Therapy Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of DsDNA Bacteriophage
Table 3. Major Players of SsDNA Bacteriophage
Table 4. Major Players of SsRNA Bacteriophage
Table 5. Major Players of Others
Table 6. Phage Therapy Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 7. Global Phage Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 8. Global Phage Therapy Market Size Market Share by Type (2016-2021)
Table 9. Phage Therapy Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 10. Global Phage Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 11. Global Phage Therapy Market Size Market Share by Application (2016-2021)
Table 12. Global Phage Therapy Revenue by Players (2019-2021E) & ($ Millions)
Table 13. Global Phage Therapy Revenue Market Share by Players (2019-2021E)
Table 14. Phage Therapy Key Players Head office and Products Offered
Table 15. Phage Therapy Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Phage Therapy Market Size by Regions 2016-2021 & ($ Millions)
Table 19. Global Phage Therapy Market Size Market Share by Regions 2016-2021
Table 20. Americas Phage Therapy Market Size by Country (2016-2021) & ($ Millions)
Table 21. Americas Phage Therapy Market Size Market Share by Country (2016-2021)
Table 22. Americas Phage Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 23. Americas Phage Therapy Market Size Market Share by Type (2016-2021)
Table 24. Americas Phage Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 25. Americas Phage Therapy Market Size Market Share by Application (2016-2021)
Table 26. APAC Phage Therapy Market Size by Region (2016-2021) & ($ Millions)
Table 27. APAC Phage Therapy Market Size Market Share by Region (2016-2021)
Table 28. APAC Phage Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 29. APAC Phage Therapy Market Size Market Share by Type (2016-2021)
Table 30. APAC Phage Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 31. APAC Phage Therapy Market Size Market Share by Application (2016-2021)
Table 32. Europe Phage Therapy Market Size by Country (2016-2021) & ($ Millions)
Table 33. Europe Phage Therapy Market Size Market Share by Country (2016-2021)
Table 34. Europe Phage Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 35. Europe Phage Therapy Market Size Market Share by Type (2016-2021)
Table 36. Europe Phage Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 37. Europe Phage Therapy Market Size Market Share by Application (2016-2021)
Table 38. Middle East & Africa Phage Therapy Market Size by Region (2016-2021) & ($ Millions)
Table 39. Middle East & Africa Phage Therapy Market Size Market Share by Region (2016-2021)
Table 40. Middle East & Africa Phage Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 41. Middle East & Africa Phage Therapy Market Size Market Share by Type (2016-2021)
Table 42. Middle East & Africa Phage Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 43. Middle East & Africa Phage Therapy Market Size Market Share by Application (2016-2021)
Table 44. Key and Potential Regions of Phage Therapy
Table 45. Key Application and Potential Industries of Phage Therapy
Table 46. Key Challenges of Phage Therapy
Table 47. Key Trends of Phage Therapy
Table 48. Global Phage Therapy Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 49. Global Phage Therapy Market Size Market Share Forecast by Regions (2021-2026)
Table 50. Global Phage Therapy Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 51. Global Phage Therapy Market Size Market Share Forecast by Type (2021-2026)
Table 52. Global Phage Therapy Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 53. Global Phage Therapy Market Size Market Share Forecast by Application (2021-2026)
Table 54. NPO Microgen Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 55. NPO Microgen Phage Therapy Product Offered
Table 56. NPO Microgen Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 57. NPO Microgen Main Business
Table 58. NPO Microgen Latest Developments
Table 59. Proteon Pharmaceuticals Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 60. Proteon Pharmaceuticals Phage Therapy Product Offered
Table 61. Proteon Pharmaceuticals Main Business
Table 62. Proteon Pharmaceuticals Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 63. Proteon Pharmaceuticals Latest Developments
Table 64. Phagelux Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 65. Phagelux Phage Therapy Product Offered
Table 66. Phagelux Main Business
Table 67. Phagelux Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 68. Phagelux Latest Developments
Table 69. Intralytix Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 70. Intralytix Phage Therapy Product Offered
Table 71. Intralytix Main Business
Table 72. Intralytix Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 73. Intralytix Latest Developments
Table 74. Micreos Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 75. Micreos Phage Therapy Product Offered
Table 76. Micreos Main Business
Table 77. Micreos Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 78. Micreos Latest Developments
Table 79. Eliava BioPreparations Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 80. Eliava BioPreparations Phage Therapy Product Offered
Table 81. Eliava BioPreparations Main Business
Table 82. Eliava BioPreparations Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 83. Eliava BioPreparations Latest Developments
Table 84. Locus Biosciences,Inc Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 85. Locus Biosciences,Inc Phage Therapy Product Offered
Table 86. Locus Biosciences,Inc Main Business
Table 87. Locus Biosciences,Inc Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 88. Locus Biosciences,Inc Latest Developments
Table 89. Pharmex Group,LLC Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 90. Pharmex Group,LLC Phage Therapy Product Offered
Table 91. Pharmex Group,LLC Main Business
Table 92. Pharmex Group,LLC Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 93. Pharmex Group,LLC Latest Developments
Table 94. Pherecydes Pharma Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 95. Pherecydes Pharma Phage Therapy Product Offered
Table 96. Pherecydes Pharma Main Business
Table 97. Pherecydes Pharma Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 98. Pherecydes Pharma Latest Developments
Table 99. APS Biocontrol Ltd. (APS) Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 100. APS Biocontrol Ltd. (APS) Phage Therapy Product Offered
Table 101. APS Biocontrol Ltd. (APS) Main Business
Table 102. APS Biocontrol Ltd. (APS) Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 103. APS Biocontrol Ltd. (APS) Latest Developments
Table 104. Qingdao Phagepharm Bio-tech Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 105. Qingdao Phagepharm Bio-tech Phage Therapy Product Offered
Table 106. Qingdao Phagepharm Bio-tech Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 107. Qingdao Phagepharm Bio-tech Main Business
Table 108. Qingdao Phagepharm Bio-tech Latest Developments
Table 109. Fixed-Phage Limited Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 110. Fixed-Phage Limited Phage Therapy Product Offered
Table 111. Fixed-Phage Limited Main Business
Table 112. Fixed-Phage Limited Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 113. Fixed-Phage Limited Latest Developments
Table 114. Zeptometrix Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 115. Zeptometrix Phage Therapy Product Offered
Table 116. Zeptometrix Main Business
Table 117. Zeptometrix Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 118. Zeptometrix Latest Developments
Table 119. Phage International, Inc. Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 120. Phage International, Inc. Phage Therapy Product Offered
Table 121. Phage International, Inc. Main Business
Table 122. Phage International, Inc. Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 123. Phage International, Inc. Latest Developments
Table 124. MicroMir Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 125. MicroMir Phage Therapy Product Offered
Table 126. MicroMir Main Business
Table 127. MicroMir Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 128. MicroMir Latest Developments
Table 129. iNtODEWORLD, Inc. Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 130. iNtODEWORLD, Inc. Phage Therapy Product Offered
Table 131. iNtODEWORLD, Inc. Main Business
Table 132. iNtODEWORLD, Inc. Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 133. iNtODEWORLD, Inc. Latest Developments
Table 134. NEXTBIOTICS Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 135. NEXTBIOTICS Phage Therapy Product Offered
Table 136. NEXTBIOTICS Main Business
Table 137. NEXTBIOTICS Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 138. NEXTBIOTICS Latest Developments
Table 139. Armata Pharmaceuticals, Inc. Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 140. Armata Pharmaceuticals, Inc. Phage Therapy Product Offered
Table 141. Armata Pharmaceuticals, Inc. Main Business
Table 142. Armata Pharmaceuticals, Inc. Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 143. Armata Pharmaceuticals, Inc. Latest Developments
Table 144. Innophage Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 145. Innophage Phage Therapy Product Offered
Table 146. Innophage Main Business
Table 147. Innophage Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 148. Innophage Latest Developments
Table 149. Adaptive Phage Therapeutics Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 150. Adaptive Phage Therapeutics Phage Therapy Product Offered
Table 151. Adaptive Phage Therapeutics Main Business
Table 152. Adaptive Phage Therapeutics Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 153. Adaptive Phage Therapeutics Latest Developments
Table 154. TechnoPhage Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 155. TechnoPhage Phage Therapy Product Offered
Table 156. TechnoPhage Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 157. TechnoPhage Main Business
Table 158. TechnoPhage Latest Developments
List of Figures
Figure 1. Phage Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Phage Therapy Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Phage Therapy Market Size Market Share by Type in 2020
Figure 7. Phage Therapy in Animal Health
Figure 8. Global Phage Therapy Market: Animal Health (2016-2021) & ($ Millions)
Figure 9. Phage Therapy in Aquaculture
Figure 10. Global Phage Therapy Market: Aquaculture (2016-2021) & ($ Millions)
Figure 11. Phage Therapy in Agriculture
Figure 12. Global Phage Therapy Market: Agriculture (2016-2021) & ($ Millions)
Figure 13. Phage Therapy in Food Industry
Figure 14. Global Phage Therapy Market: Food Industry (2016-2021) & ($ Millions)
Figure 15. Phage Therapy in Human Health
Figure 16. Global Phage Therapy Market: Human Health (2016-2021) & ($ Millions)
Figure 17. Phage Therapy in Others
Figure 18. Global Phage Therapy Market: Others (2016-2021) & ($ Millions)
Figure 19. Global Phage Therapy Market Size Market Share by Application in 2020
Figure 20. Global Phage Therapy Revenue Market Share by Player in 2020
Figure 21. Global Phage Therapy Market Size Market Share by Regions (2016-2021)
Figure 22. Americas Phage Therapy Market Size 2016-2021 ($ Millions)
Figure 23. APAC Phage Therapy Market Size 2016-2021 ($ Millions)
Figure 24. Europe Phage Therapy Market Size 2016-2021 ($ Millions)
Figure 25. Middle East & Africa Phage Therapy Market Size 2016-2021 ($ Millions)
Figure 26. Americas Phage Therapy Market Size Market Share by Country in 2020
Figure 27. Americas Phage Therapy Market Size Market Share by Type in 2020
Figure 28. Americas Phage Therapy Market Size Market Share by Application in 2020
Figure 29. United States Phage Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 30. Canada Phage Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 31. Mexico Phage Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 32. APAC Phage Therapy Market Size Market Share by Regions in 2020
Figure 33. APAC Phage Therapy Market Size Market Share by Type in 2020
Figure 34. APAC Phage Therapy Market Size Market Share by Application in 2020
Figure 35. China Phage Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 36. Japan Phage Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 37. Korea Phage Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 38. Southeast Asia Phage Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 39. India Phage Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 40. Australia Phage Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 41. Europe Phage Therapy Market Size Market Share by Country in 2020
Figure 42. Europe Phage Therapy Market Size Market Share by Type in 2020
Figure 43. Europe Phage Therapy Market Size Market Share by Application in 2020
Figure 44. Germany Phage Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 45. France Phage Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 46. UK Phage Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 47. Italy Phage Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 48. Russia Phage Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 49. Middle East & Africa Phage Therapy Market Size Market Share by Region in 2020
Figure 50. Middle East & Africa Phage Therapy Market Size Market Share by Type in 2020
Figure 51. Middle East & Africa Phage Therapy Market Size Market Share by Application in 2020
Figure 52. Egypt Phage Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 53. South Africa Phage Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 54. Israel Phage Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 55. Turkey Phage Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 56. GCC Country Phage Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 57. Americas Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 58. APAC Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 59. Europe Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 60. Middle East & Africa Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 61. United States Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 62. Canada Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 63. Mexico Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 64. Brazil Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 65. China Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 66. Japan Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 67. Korea Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 68. Southeast Asia Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 69. India Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 70. Australia Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 71. Germany Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 72. France Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 73. UK Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 74. Italy Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 75. Russia Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 76. Spain Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 77. Egypt Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 78. South Africa Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 79. Israel Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 80. Turkey Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 81. GCC Country Phage Therapy Market Size 2021-2026 ($ Millions)

※본 조사보고서 [세계의 파지 요법 시장예측 2021년-2026년] (코드 : LPI-2201K02268) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 파지 요법 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 혈우병 유전자 치료 시장예측 2021년-2026년
LPI-2201K00120 / LP Information / 2021년 12월 / 본 조사보고서는 혈우병 유전자 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Hemophilia Gene Therapy will have significant change from previous year. By the most conservative estimates of global Hemophilia Gene Therapy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 플라즈마 요법 시장예측 2021년-2026년
LPI-2201K02280 / LP Information / 2021년 12월 / 본 조사보고서는 플라즈마 요법의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Plasma Therapy will have significant change from previous year. By the most conservative estimates of global Plasma Therapy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 239.8 million in 2020. Over...

세계의 줄기 세포 치료 시장예측 2021년-2026년
LPI-2201K02308 / LP Information / 2021년 12월 / 본 조사보고서는 줄기 세포 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Stem Cell Therapy will have significant change from previous year. By the most conservative estimates of global Stem Cell Therapy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 387.3 million in...

세계의 사운드 테라피 시장예측 2021년-2026년
LPI-2201K02303 / LP Information / 2021년 12월 / 본 조사보고서는 사운드 테라피의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Sound Therapy will have significant change from previous year. By the most conservative estimates of global Sound Therapy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over...

세계의 혈전 용해 요법 시장예측 2021년-2026년
LPI-2201K02316 / LP Information / 2021년 12월 / 본 조사보고서는 혈전 용해 요법의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Thrombolytic Therapy will have significant change from previous year. By the most conservative estimates of global Thrombolytic Therapy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 31150 million in 2020. Over...

세계의 혈우병 A 및 B 재조합 인자 대체 요법 시장예측 2021년-2026년
LPI-2201K00119 / LP Information / 2021년 12월 / 본 조사보고서는 혈우병 A 및 B 재조합 인자 대체 요법의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아,...According to this latest study, the 2021 growth of Hemophilia A and B Recombinant Factor Replacement Therapy will have significant change from previous year. By the most conservative estimates of global Hemophilia A and B Recombinant Factor Replacement Therapy market size (most likely outcome) will be a year-over-year revenue growth...

세계의 내추럴 킬러 세포 치료법 시장예측 2021년-2026년
LPI-2201K02238 / LP Information / 2021년 12월 / 본 조사보고서는 내추럴 킬러 세포 치료법의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Natural Killer Cell Therapy will have significant change from previous year. By the most conservative estimates of global Natural Killer Cell Therapy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 201.5...

세계의 조직 재생 요법 시장예측 2021년-2026년
LPI-2201K02318 / LP Information / 2021년 12월 / 본 조사보고서는 조직 재생 요법의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Tissue Regenerative Therapy will have significant change from previous year. By the most conservative estimates of global Tissue Regenerative Therapy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ XX million in...